These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33065206)

  • 1. Knockout mouse models are predictive of malformations or embryo-fetal death in drug safety evaluations.
    Catlin NR; Stethem C; Bowman CJ; Campion SN; Nowland WS; Cappon GD
    Reprod Toxicol; 2021 Jan; 99():138-143. PubMed ID: 33065206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockout mouse models are predictive of malformations or embryo-fetal death in drug safety evaluations.
    Catlin NR; Stethem CM; Bowman CJ; Campion SN; Nowland WS; Cappon GD
    Reprod Toxicol; 2020 Sep; 96():11-16. PubMed ID: 32522587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2018 and 2019.
    Barrow P; Clemann N
    Reprod Toxicol; 2021 Jan; 99():144-151. PubMed ID: 32593570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictivity of preliminary embryo-fetal development (EFD) studies: results of a retrospective survey in Japanese pharmaceutical companies.
    Okahashi N; Ikeda T; Kai S; Komatsu S; Matsui H; Yamashita Y; Yamamoto K; Sagami F
    J Toxicol Sci; 2010 Feb; 35(1):21-31. PubMed ID: 20118621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of rat and rabbit embryo-fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects.
    Theunissen PT; Beken S; Beyer BK; Breslin WJ; Cappon GD; Chen CL; Chmielewski G; De Schaepdrijver L; Enright B; Foreman JE; Harrouk W; Hew KW; Hoberman AM; Hui JY; Knudsen TB; Laffan SB; Makris SL; Martin M; McNerney ME; Siezen CL; Stanislaus DJ; Stewart J; Thompson KE; Tornesi B; Van der Laan JW; Weinbauer GF; Wood S; Piersma AH
    Crit Rev Toxicol; 2016 Nov; 46(10):900-910. PubMed ID: 27848393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Numeric Estimates of Teratogenic Severity from Embryo-Fetal Developmental Toxicity Studies.
    Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2016 Feb; 107(1):60-70. PubMed ID: 26848810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between maternal toxicity and embryo/fetal effects.
    Chahoud I; Ligensa A; Dietzel L; Faqi AS
    Reprod Toxicol; 1999; 13(5):375-81. PubMed ID: 10560586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of human serum for studying malformations in whole embryo cultures.
    Beck F; Gulamhusein AP; Huxham IM
    Prog Clin Biol Res; 1985; 163C():265-70. PubMed ID: 3991629
    [No Abstract]   [Full Text] [Related]  

  • 10. [Embryotoxic properties of drugs].
    Smol'nikova NM; Golovanova IV; Proĭnova VA; Skosyreva AM; Strekalova SN
    Farmakol Toksikol; 1982; 45(4):115-9. PubMed ID: 6751867
    [No Abstract]   [Full Text] [Related]  

  • 11. Developmental and reproductive toxicity testing of vaccines.
    Barrow P
    J Pharmacol Toxicol Methods; 2012 Mar; 65(2):58-63. PubMed ID: 22233769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance of 3 alternative teratogenicity assays with results from corresponding in vivo embryo-fetal development studies: Final report from the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) DruSafe working group 2.
    McNerney M; Potter D; Augustine-Rauch K; Barrow P; Beyer B; Brannen K; Engel S; Enright BP; Nowland WS; Powles-Glover N; Powlin S; Schneidkraut MJ; Stanislaus D; Turner K; Graziano M
    Regul Toxicol Pharmacol; 2021 Aug; 124():104984. PubMed ID: 34216694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The threshold of toxicological concern for prenatal developmental toxicity in rabbits and a comparison to TTC values in rats.
    van Ravenzwaay B; Dammann M; Buesen R; Flick B; Schneider S
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):1-8. PubMed ID: 22705707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing strategies for embryo-fetal toxicity of human pharmaceuticals. Animal models vs. in vitro approaches: a workshop report.
    van der Laan JW; Chapin RE; Haenen B; Jacobs AC; Piersma A
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):115-23. PubMed ID: 22449444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2016 and 2017.
    Barrow P
    Reprod Toxicol; 2018 Sep; 80():117-125. PubMed ID: 29660390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of exposure margins in developmental toxicity studies for detection of human teratogens.
    Andrews PA; Blanset D; Costa PL; Green M; Green ML; Jacobs A; Kadaba R; Lebron JA; Mattson B; McNerney ME; Minck D; Oliveira LC; Theunissen PT; DeGeorge JJ
    Regul Toxicol Pharmacol; 2019 Jul; 105():62-68. PubMed ID: 30981719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole embryo culture: a screening technique for teratogens?
    Sadler TW; Horton WE; Warner CW
    Teratog Carcinog Mutagen; 1982; 2(3-4):243-53. PubMed ID: 6130624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of postimplantation mammalian embryo culture in the study of teratogenic mechanisms.
    Steele CE
    Prog Clin Biol Res; 1985; 163C():271-6. PubMed ID: 3991630
    [No Abstract]   [Full Text] [Related]  

  • 20. Atenolol developmental toxicity: animal-to-human comparisons.
    Tabacova S; Kimmel CA; Wall K; Hansen D
    Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):181-92. PubMed ID: 12797460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.